Ropinirole and Pramipexole Promote Structural Plasticity in Human iPSC-Derived Dopaminergic Neurons via BDNF and mTOR Signaling

The antiparkinsonian ropinirole and pramipexole are D3 receptor- (D3R-) preferring dopaminergic (DA) agonists used as adjunctive therapeutics for the treatment resistant depression (TRD). While the exact antidepressant mechanism of action remains uncertain, a role for D3R in the restoration of impai...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Neural plasticity. - 1998. - 2018(2018) vom: 17., Seite 4196961
1. Verfasser: Collo, Ginetta (VerfasserIn)
Weitere Verfasser: Cavalleri, Laura, Bono, Federica, Mora, Cristina, Fedele, Stefania, Invernizzi, Roberto William, Gennarelli, Massimo, Piovani, Giovanna, Kunath, Tilo, Millan, Mark J, Merlo Pich, Emilio, Spano, PierFranco
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2018
Zugriff auf das übergeordnete Werk:Neural plasticity
Schlagworte:Journal Article Research Support, Non-U.S. Gov't Antiparkinson Agents Benzothiazoles Brain-Derived Neurotrophic Factor Indoles ropinirole 030PYR8953 BDNF protein, human 7171WSG8A2 mehr... Pramipexole 83619PEU5T MTOR protein, human EC 2.7.1.1 TOR Serine-Threonine Kinases EC 2.7.11.1
LEADER 01000caa a22002652 4500
001 NLM281879559
003 DE-627
005 20250223070935.0
007 cr uuu---uuuuu
008 231225s2018 xx |||||o 00| ||eng c
024 7 |a 10.1155/2018/4196961  |2 doi 
028 5 2 |a pubmed25n0939.xml 
035 |a (DE-627)NLM281879559 
035 |a (NLM)29531524 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Collo, Ginetta  |e verfasserin  |4 aut 
245 1 0 |a Ropinirole and Pramipexole Promote Structural Plasticity in Human iPSC-Derived Dopaminergic Neurons via BDNF and mTOR Signaling 
264 1 |c 2018 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 27.11.2018 
500 |a Date Revised 04.12.2021 
500 |a published: Electronic-eCollection 
500 |a Citation Status MEDLINE 
520 |a The antiparkinsonian ropinirole and pramipexole are D3 receptor- (D3R-) preferring dopaminergic (DA) agonists used as adjunctive therapeutics for the treatment resistant depression (TRD). While the exact antidepressant mechanism of action remains uncertain, a role for D3R in the restoration of impaired neuroplasticity occurring in TRD has been proposed. Since D3R agonists are highly expressed on DA neurons in humans, we studied the effect of ropinirole and pramipexole on structural plasticity using a translational model of human-inducible pluripotent stem cells (hiPSCs). Two hiPSC clones from healthy donors were differentiated into midbrain DA neurons. Ropinirole and pramipexole produced dose-dependent increases of dendritic arborization and soma size after 3 days of culture, effects antagonized by the selective D3R antagonists SB277011-A and S33084 and by the mTOR pathway kinase inhibitors LY294002 and rapamycin. All treatments were also effective in attenuating the D3R-dependent increase of p70S6-kinase phosphorylation. Immunoneutralisation of BDNF, inhibition of TrkB receptors, and blockade of MEK-ERK signaling likewise prevented ropinirole-induced structural plasticity, suggesting a critical interaction between BDNF and D3R signaling pathways. The highly similar profiles of data acquired with DA neurons derived from two hiPSC clones underpin their reliability for characterization of pharmacological agents acting via dopaminergic mechanisms 
650 4 |a Journal Article 
650 4 |a Research Support, Non-U.S. Gov't 
650 7 |a Antiparkinson Agents  |2 NLM 
650 7 |a Benzothiazoles  |2 NLM 
650 7 |a Brain-Derived Neurotrophic Factor  |2 NLM 
650 7 |a Indoles  |2 NLM 
650 7 |a ropinirole  |2 NLM 
650 7 |a 030PYR8953  |2 NLM 
650 7 |a BDNF protein, human  |2 NLM 
650 7 |a 7171WSG8A2  |2 NLM 
650 7 |a Pramipexole  |2 NLM 
650 7 |a 83619PEU5T  |2 NLM 
650 7 |a MTOR protein, human  |2 NLM 
650 7 |a EC 2.7.1.1  |2 NLM 
650 7 |a TOR Serine-Threonine Kinases  |2 NLM 
650 7 |a EC 2.7.11.1  |2 NLM 
700 1 |a Cavalleri, Laura  |e verfasserin  |4 aut 
700 1 |a Bono, Federica  |e verfasserin  |4 aut 
700 1 |a Mora, Cristina  |e verfasserin  |4 aut 
700 1 |a Fedele, Stefania  |e verfasserin  |4 aut 
700 1 |a Invernizzi, Roberto William  |e verfasserin  |4 aut 
700 1 |a Gennarelli, Massimo  |e verfasserin  |4 aut 
700 1 |a Piovani, Giovanna  |e verfasserin  |4 aut 
700 1 |a Kunath, Tilo  |e verfasserin  |4 aut 
700 1 |a Millan, Mark J  |e verfasserin  |4 aut 
700 1 |a Merlo Pich, Emilio  |e verfasserin  |4 aut 
700 1 |a Spano, PierFranco  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Neural plasticity  |d 1998  |g 2018(2018) vom: 17., Seite 4196961  |w (DE-627)NLM098558390  |x 1687-5443  |7 nnns 
773 1 8 |g volume:2018  |g year:2018  |g day:17  |g pages:4196961 
856 4 0 |u http://dx.doi.org/10.1155/2018/4196961  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_21 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 2018  |j 2018  |b 17  |h 4196961